Martin H. Huber Jr. - 15 Sep 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
15 Sep 2021
Net transactions value
+$677,600
Form type
4
Filing time
17 Sep 2021, 16:32:54 UTC
Previous filing
15 Jun 2021
Next filing
21 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Award $677,600 +35,000 $19.36 35,000 15 Sep 2021 Common Stock 35,000 $19.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest monthly over a three-year period.